2025-05-12 20:56:00

US stocks related to weight loss drugs accelerated their decline before the market opened, with Eli Lilly (LLY.N) and Novo Nordisk (NVO.N) falling by more than 5%. White House officials said they expect diabetes and weight loss drugs to become the focus of drug price reduction.
Email Subscription
Newsletters and emails are now available! Delivered on time, every weekday, to keep you up to date with North American business news.
ASIA TECH WIRE

Grasp technology trends

Download